BioVersys AG

BIOV

Company Profile

  • Business description

    BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The company focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others.

  • Contact

    c/o Technologiepark
    Hochbergerstrasse 60c
    BaselCH-4057
    CHE

    T: +41 615515120

    https://www.bioversys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,828.702.300.03%
CAC 407,765.0241.550.54%
DAX 4024,205.07131.400.55%
Dow JONES (US)44,273.79132.57-0.30%
FTSE 1008,847.7241.190.47%
HKSE24,148.07260.241.09%
NASDAQ20,387.3025.22-0.12%
Nikkei 22539,688.81101.130.26%
NZX 50 Index12,859.0294.070.74%
S&P 5006,221.378.61-0.14%
S&P/ASX 2008,590.701.400.02%
SSE Composite Index3,497.4824.350.70%

Market Movers